Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Cariprazine-D8 Solution, 100 μg/mL (0.1% HCl in Acetonitrile (v/v)), Sold by MilliporeSigma™ Supelco™

Certified reference material

Manufacturer:  MilliporeSigma Supelco C1791ML

Catalog No. 01-001-130


Due to product restrictions, please to purchase or view availability for this product.


Description

Description

Cariprazine, sold as Vraylar in the US and Reagila in Europe, is an atypical antipsychotic used in the treatment of schizophrenia and bipolar mania. This stable-labeled internal standard is suitable for quantitation of Cariprazine levels in urine, serum, or plasma by LC/MS or GC/MS for clinical toxicology, forensic analysis, and urine drug testing applications.
Specifications

Specifications

75-05-8, 1308278-50-3
100 μg/mL (0.1% HCl in acetonitrile (v/v))
Ampule
1 mL
C21H24D8Cl2N4O
435.46
-20°C
2°C (35.6°F) - closed cup
Safety and Handling

Safety and Handling

H332-H319

H312

SDS
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

CERILLIANT is a registered trademark of Cerilliant Corporation